stockrowAbivax SA Sponsored ADR
ABVX Healthcare Biotechnology
- EPS
- −98.8%
- Free cash flow
- −48.3%
- Total debt
- −98.5%
Quarter to June 2026, against a year earlier
Follow ABVX
Alert me
Abivax SA Sponsored ADR (ABVX) Free cash flow
Abivax SA Sponsored ADR's free cash flow for fiscal 2025 was −$182.5M, compared with −$167.4M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$226.1M. Over the past ten years it has ranged from −$182.5M (fiscal 2025) to −$17.2M (fiscal 2018) — the current reading is the lowest in ten years. Free cash flow has fallen for 7 consecutive fiscal years. Abivax SA Sponsored ADR ranks 550th of 603 Biotechnology companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$182.5M | — |
| FY2024 | −$167.4M | — |
| FY2023 | −$105.4M | — |
| FY2022 | −$57.2M | — |
| FY2021 | −$54.0M | — |
| FY2020 | −$34.0M | — |
| FY2019 | −$30.7M | — |
| FY2018 | −$17.2M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | −$60.2M | — |
| Mar 2026 | −$59.2M | — |
| Dec 2025 | −$21.2M | — |
| Sep 2025 | −$85.6M | — |
| 10 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| CORT Corcept Therapeutics Incorporated compare | $194.6M |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | −$75.1M |
| RYTM Rhythm Pharmaceuticals, Inc. compare | −$81.8M |
| AXSM Axsome Therapeutics, Inc. compare | −$82.6M |
| ORKA Oruka Therapeutics, Inc. compare | −$101.2M |
| ABVX Abivax SA Sponsored ADR | −$226.1M |
| SYRE Spyre Therapeutics, Inc. compare | −$249.3M |
| PRAX Praxis Precision Medicines, Inc. compare | −$306.2M |
| CYTK Cytokinetics, Incorporated compare | −$588.6M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)